(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

T

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

T

ST13

US500000079386129

Classe

5, 9, 10, 42, 44

Pedido

79386129

Registro

7772609

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

30/07/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 9, 10, 42, 44

Data de depósito

14/11/2023

Data de registro

29/04/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/04/2025

Última transação

30/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

99

Localização do titular

AU

Examinador

FEDERICO, EVAN G

Unidade examinadora

O40

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of four blue triangles facing inward to form a circle containing a stylized lowercase letter "T". There is a blue circle in the center of the four triangles. The color white serves as background areas and is not claimed as a feature of the mark.

Titulares e representantes

Titulares

Telix Pharmaceuticals Limited

Representantes

Andrew S. Ehard

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; Contrast media for use with medical equipment; Diagnostic agents for medical use in in vivo scanning; Compositions for medical use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, cancer; Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer

Classe 9

Downloadable computer operating software; Downloadable computer application software for mobile phones, portable media players, and handheld computers, namely, software for the treatment, prevention, or diagnosis of cancer; Software as a Medical Device (SaMD), downloadable, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for medical purposes, namely, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for the treatment, prevention, or diagnosis of cancer

Classe 10

Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; medical apparatus for use in laparoscopy; Medical apparatus for detecting cancer; Surgical instruments and apparatus; detecting instruments for medical use for detecting cancer; Medical instruments for use in the treatment, prevention, or diagnosis of cancer; Test equipment for medical use, namely, medical diagnostic instrument for cancer; diagnostic imaging apparatus for medical use; medical imaging apparatus; Probes for medical purposes; surgical instruments in the nature of surgical probes; surgical robots; nanorobots for medical purposes for surgical use

Classe 42

Software as a service (SAAS) services featuring software for the treatment, prevention, or diagnosis of cancer; computer software design; computer software development; computer software programming services for others in the field of medicine; development of software for the treatment, prevention, or diagnosis of cancer; Software as a service (SAAS) services, namely, hosting software for use by others for the treatment, prevention, or diagnosis of cancer; installation of computer software; software creation in the nature of computer software design; software engineering services; Design and writing of computer software; online provision of web-based applications, namely, providing temporary use of on-line non-downloadable applications for the treatment, prevention, and diagnosis of cancer; online provision of web-based software, namely, providing temporary use of online non-downloadable software for the treatment, prevention, or diagnosis of cancer; Consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology

Classe 44

Medical analysis services for the diagnosis and treatment of persons with cancer; medical analysis services relating to the treatment of persons; medical diagnostic services; medical health assessment services; services for the preparation of medical reports, namely, providing medical information to patients, in the form of reports in the field of cancer; advisory services relating to medical services; consultancy and advisory services in relation to medical services; provision of medical information; Consulting services in the field of healthcare; health screening services in the field of cancer; providing information relating to health care services; preparation of reports relating to health care matters for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

30/07/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

22/01/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/01/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/12/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

15/11/2025

FIMP

FINAL DISPOSITION PROCESSED

14/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

29/07/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

13/06/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/05/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

27/05/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

29/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

29/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2025

PUBO

PUBLISHED FOR OPPOSITION

11/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2025

ALIE

ASSIGNED TO LIE

18/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/02/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

13/02/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

13/02/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

13/02/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

13/02/2025

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

13/02/2025

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

11/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/01/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

27/01/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

27/01/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

27/01/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

27/01/2025

DOCK

ASSIGNED TO EXAMINER

26/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/10/2024

RFNT

REFUSAL PROCESSED BY IB

01/05/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/04/2024

RFRR

REFUSAL PROCESSED BY MPU

06/04/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

19/03/2024

CNRT

NON-FINAL ACTION WRITTEN

18/03/2024

DOCK

ASSIGNED TO EXAMINER

14/03/2024

MAFR

APPLICATION FILING RECEIPT MAILED

02/01/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

29/12/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/12/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace T ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.